This inventor holds 1 USPTO granted patent. Top assignee: Dainippon Pharmaceutical Company, Limited. Active years: 1994.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1994
Title: Juniti Yamagishi: Innovator in Tumor Necrosis Factor Research
Introduction
Juniti Yamagishi is a prominent inventor based in Toyonaka, Japan. He is known for his significant contributions to the field of biotechnology, particularly in the area of tumor necrosis factor (TNF) research. His work has implications for understanding and treating various diseases.
Latest Patents
Yamagishi holds a patent for "Human tumor necrosis factor polypeptides." This patent includes a novel cloned DNA encoding a human tumor necrosis factor (TNF), a vector containing this DNA, a host transformed with the vector, and a novel human TNF polypeptide. The processes for producing these elements are also covered in his patent.
Career Highlights
Yamagishi is associated with Dainippon Pharmaceutical Company, Limited, where he has been instrumental in advancing research and development in pharmaceuticals. His innovative work has led to a better understanding of TNF and its role in human health.
Collaborations
Throughout his career, Yamagishi has collaborated with notable colleagues, including Masaaki Yamada and Yasuji Furutani. These collaborations have further enriched his research and contributed to the scientific community.
Conclusion
Juniti Yamagishi's contributions to the field of biotechnology, particularly through his patent on human tumor necrosis factor polypeptides, highlight his role as an influential inventor. His work continues to impact the understanding of TNF and its applications in medicine.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile